Between now and the end of the year the likelihood of a backtrack of 10% or more is Low, and the likelihood of an increase in SP by 10% or more is high. Still a buy proposition on the balance of probabilities.
- Forums
- ASX - By Stock
- CGB
- Current SP
Current SP, page-655
-
- There are more pages in this discussion • 1,371 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CGB (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online